XClinical is a leading eClinical technology solutions company, offering its CDISC-certified Electronic Data Capture (EDC) and Data Management (DM) system MARVIN and related tools such as the STUDY COMPOSER and the TABULATOR.
The combined solutions, ECLINSO’s Trialforce Platform and XClinical’s EDC system MARVIN, offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CRO’s) for capturing and managing their clinical data. Trialforce, a managed application platform, is fully compliant to the following industry standards 21 CFR 11, CDISC, HIPAA, W3C, and GCP with support for over 50 languages (including double byte languages such as Chinese).
Trialforce is a cloud-based platform with no local software or hardware to support. Based on a Software as a Service (SaaS) pricing model there are minimal upfront costs, significantly lowering the initial licensing fees traditionally associated with EDC and Data Management solutions.
MARVIN can be used across all types of therapeutic areas; adapting to any type of clinical trial including Phase I-IV interventional studies, medical device trials, observational studies, registry trials, prevention studies, genetic investigations, diagnostic trials, and outcomes research. MARVIN is built on CDISC standards that enable pharmaceutical companies, CROs and MedTech companies to increase clinical trial efficiency.
STUDY COMPOSER, the EDC design tool, offers an intuitive graphical point-and-click interface for defining a trial and creating relevant metadata. Study Composer automatically generates the eCRF design; the annotated CRF and data validation plan with a click of a button- all CDISC ODM compliant from the start. The solution accelerates the whole clinical trial process and thus saves time and money.
Combined with trialforce, MARVIN offers unparalleled visibility, exception management, and analysis of information from clinical trials, enabling trial sponsors and managers to make critical decisions during and throughout a trial. Integration and interoperability through other Trialforce solutions, such as IVR and ePRO, can be provided easily and seamlessly.
"ECLINSO is extremely pleased to be able to offer MARVIN. XClinical shares our philosophy of providing innovative solutions based on industry standards, which enables interoperability within our trialforce platform. The convergence of cloud-based solutions such as Trialforce with MARVIN will significantly improve clinical trial efficiency while reducing costs." Said Frank Pijpers, CEO of ECLINSO.
"XClinical is delighted to have reached this partnership agreement with ECLINSO. It enables us to offer an enterprise-level delivery and support channel for our solutions." Said Philippe Verplancke, CEO of XClinical.